iohexol has been researched along with Anemia in 1 studies
Iohexol: An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.
iohexol : A benzenedicarboxamide compound having N-(2,3-dihydroxypropyl)carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and an N-(2,3-dihydroxypropyl)acetamido group at the 5-position.
Anemia: A reduction in the number of circulating ERYTHROCYTES or in the quantity of HEMOGLOBIN.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Murakami, R | 1 |
| Kumita, S | 1 |
| Hayashi, H | 1 |
| Sugizaki, K | 1 |
| Okazaki, E | 1 |
| Kiriyama, T | 1 |
| Hakozaki, K | 1 |
| Tani, H | 1 |
| Miki, I | 1 |
| Takeda, M | 1 |
1 other study available for iohexol and Anemia
| Article | Year |
|---|---|
Anemia and the risk of contrast-induced nephropathy in patients with renal insufficiency undergoing contrast-enhanced MDCT.
Topics: Acute Kidney Injury; Aged; Anemia; Causality; Comorbidity; Contrast Media; Drug-Related Side Effects | 2013 |